Literature DB >> 2864058

Celiprolol, clinical dosage, efficacy and safety in asthmatic and elderly patients.

G Hitzenberger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2864058

Source DB:  PubMed          Journal:  Br J Clin Pract Suppl        ISSN: 0262-8767


× No keyword cloud information.
  5 in total

Review 1.  Newer beta blockers and the treatment of hypertension.

Authors:  D McAreavey; R Vermeulen; J I Robertson
Journal:  Cardiovasc Drugs Ther       Date:  1991-06       Impact factor: 3.727

2.  Pharmacology of celiprolol.

Authors:  W J Louis; O H Drummer; L H Tung
Journal:  Cardiovasc Drugs Ther       Date:  1991-01       Impact factor: 3.727

3.  Comparison of ketanserin and celiprolol on regression of left ventricular hypertrophy in older hypertensive patients.

Authors:  G P Vyssoulis; E A Karpanou; C E Pitsavos; T K Kourtis; A A Paleologos; P K Toutouzas
Journal:  Cardiovasc Drugs Ther       Date:  1992-08       Impact factor: 3.727

4.  Comparative effects of celiprolol, propranolol, oxprenolol, and atenolol on respiratory function in hypertensive patients with chronic obstructive lung disease.

Authors:  R Fogari; A Zoppi; F Tettamanti; L Poletti; G Rizzardi; G Fiocchi
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

Review 5.  Celiprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties and its therapeutic use in hypertension and angina pectoris.

Authors:  J G Riddell; R G Shanks; R N Brogden
Journal:  Drugs       Date:  1987-10       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.